PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
Visit https://www.peervoice.com/JEG860 to view the entire programme with slides. After completing “Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis”, participants will be able to: Describe the limitations of current targeted immunotherapies for patients with generalised myasthenia gravis (gMG); Identify emerging targeted therapies for gMG; and Explain how emerging targeted therapies for gMG differentiate from other therapies within the same class.